CA2410699C - Procedes et compositions pour inhiber l'angiogenese - Google Patents

Procedes et compositions pour inhiber l'angiogenese Download PDF

Info

Publication number
CA2410699C
CA2410699C CA002410699A CA2410699A CA2410699C CA 2410699 C CA2410699 C CA 2410699C CA 002410699 A CA002410699 A CA 002410699A CA 2410699 A CA2410699 A CA 2410699A CA 2410699 C CA2410699 C CA 2410699C
Authority
CA
Canada
Prior art keywords
sled
cells
angiogenesis
skin
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002410699A
Other languages
English (en)
Other versions
CA2410699A1 (fr
Inventor
Noel P. Bouck
David W. Dawson
Paul R. Gillis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwestern University
Original Assignee
Northwestern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwestern University filed Critical Northwestern University
Priority claimed from CA002298018A external-priority patent/CA2298018C/fr
Publication of CA2410699A1 publication Critical patent/CA2410699A1/fr
Application granted granted Critical
Publication of CA2410699C publication Critical patent/CA2410699C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002410699A 1997-07-23 1998-07-23 Procedes et compositions pour inhiber l'angiogenese Expired - Fee Related CA2410699C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89930497A 1997-07-23 1997-07-23
US08/899,304 1997-07-23
CA002298018A CA2298018C (fr) 1997-07-23 1998-07-23 Procedes et compositions pour inhiber l'angiogenese

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002298018A Division CA2298018C (fr) 1997-07-23 1998-07-23 Procedes et compositions pour inhiber l'angiogenese

Publications (2)

Publication Number Publication Date
CA2410699A1 CA2410699A1 (fr) 1999-02-04
CA2410699C true CA2410699C (fr) 2004-06-29

Family

ID=32657351

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002410699A Expired - Fee Related CA2410699C (fr) 1997-07-23 1998-07-23 Procedes et compositions pour inhiber l'angiogenese

Country Status (1)

Country Link
CA (1) CA2410699C (fr)

Also Published As

Publication number Publication date
CA2410699A1 (fr) 1999-02-04

Similar Documents

Publication Publication Date Title
CA2298018C (fr) Procedes et compositions pour inhiber l'angiogenese
Duh et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth
JP5108797B2 (ja) 色素上皮誘導因子：ｐｅｄｆ遺伝子の特性評価、ゲノム構成および配列
Bloch et al. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing
Stallmeyer et al. A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair
JP2007509984A (ja) 色素上皮由来因子、その新規な生物活性及びその使用方法
US7723313B2 (en) Methods and compositions for inhibiting angiogenesis
US6797691B1 (en) Methods and compositions for inhibiting angiogenesis
US6933277B2 (en) Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides
US20030064917A1 (en) Methods and compositions for inhibiting angiogenesis
EP1265627B1 (fr) Compositions pharmaceutiques permettant d'inhiber l'angiogenese par des fragments de pedf
CA2410699C (fr) Procedes et compositions pour inhiber l'angiogenese
US6248351B1 (en) Human PEA3 is a tumor suppressor for cancer cells
AU713364B2 (en) Transforming growth factor alpha HII
US7105156B1 (en) Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
US8168590B2 (en) Use of proteolysis resistant active VEGF
US20050164909A1 (en) Methods and reagents for treating inflammation and fibrosis
JP3375997B2 (ja) 血管内皮細胞増殖促進剤
CN117959442A (zh) 预防或治疗肺纤维化的试剂及应用
EP1013280A1 (fr) Preparations pour la peau et a usage externe

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed